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Epicardial EMTvascular formation include the epithelial–mesenchyme transition (EMT) that
epicardial cells undergo to become sub-epicardial; the invasion of the myocardium; and the differentiation
of coronary lineages. However, the factors controlling these processes are not completely understood.
Epicardial and coronary vascular precursors migrate to the avascular heart tube during embryogenesis via
the proepicardium (PE). Here, we show that in the quail embryo ﬁbroblast growth factor receptor (FGFR)-1
is expressed in a spatially and temporally restricted manner in the PE and epicardium-derived cells,
including vascular endothelial precursors, and is up-regulated in epicardial cells after EMT. We used
replication-defective retroviral vectors to over-express or knock-down FGFR-1 in the PE. FGFR-1 over-
expression resulted in increased epicardial EMT. Knock-down of FGFR-1, however, did not inhibit epicardial
EMT but greatly compromised the ability of PE progeny to invade the myocardium. The latter could,
however, contribute to endothelia and smooth muscle of sub-epicardial vessels. Correct FGFR-1 levels were
also important for correct coronary lineage differentiation with, at E12, an increase in the proportion of
endothelial cells amongst FGFR-1 over-expressing PE progeny and a decrease in the proportion of smooth
muscle cells in antisense FGFR-1 virus-infected PE progeny. Finally, in a heart explant system, constitutive
activation of FGFR-1 signaling in epicardial cells resulted in increased delamination from the epicardium,
invasion of the sub-epicardium, and invasion of the myocardium. These data reveal novel roles for FGFR-1
signaling in epicardial biology and coronary vascular lineage differentiation, and point to potential new
therapeutic avenues.
© 2009 Elsevier Inc. All rights reserved.Introduction
The coronary vasculature is essential for heart function, yet the
processes that govern its formation are incompletely understood.
Endothelial and smooth muscle cells of the coronary vasculature are
derived from the epicardium and its transient precursor, the
proepicardium (PE; Dettman et al., 1998; Mikawa and Fischman,
1992; Mikawa and Gourdie, 1996; Pérez-Pomares et al., 1998). Before
formation of the epicardium, the primitive heart tube consists of two
layers, the myocardium and endocardium (Manasek, 1969). The PE
appears as a grape-like cluster of cells, comprising villus protrusions,
that emanates from the pericardial serosa posterior to the sino-atrium
(Hiruma and Hirakow, 1989; Ho and Shimada, 1978; Virágh and
Challice,1981; Virágh et al., 1993). The PE appears to be induced by the
liver bud (Ishii et al., 2007) and during development extends to the
double-walled heart tube, probably with the aid of an extracellular
matrix bridge between it and the myocardium (Nahirney et al., 2003).
It then envelops the developing heart, thus giving rise to thel rights reserved.epicardium, the outer, mesothelial layer of the heart (Hiruma and
Hirakow, 1989; Ho and Shimada, 1978; Virágh and Challice, 1981).
Epicardium-derived cells form a coronary capillary plexus by a
vasculogenic process (Mikawa and Fischman, 1992) that is remodeled
into a mature coronary vasculature (reviewed by Bernanke and
Velkey, 2002). Recent studies have indicated that PE identity is reliant
on correct bone morphogenetic protein (BMP) and ﬁbroblast growth
factor (FGF) signaling (Kruithof et al., 2006; Schlueter et al., 2006).
A critical step in coronary vascular formation is the epithelial–
mesenchyme transition (EMT) that epicardial cells undergo to invade
the sub-epicardium (Virágh et al., 1993). Another is the decision to
contribute to the sub-epicardial coronary vasculature or, alternatively, to
invade themyocardium and contribute to intramural vessels. Fibroblast
growth factor (FGF)s and transforming growth factor β (TGFβ)s
expressed in the myocardium have been implicated in epicardial EMT,
delamination, and invasion of the sub-epicardium(Dettmanet al., 2003;
Dokic and Dettman, 2006; Morabito et al., 2001). However, it remains
unclear why only a portion of the epicardial cells undergoes EMTwhilst
others remain a part of the epicardium. Furthermore, the intrinsic
factors that determinewhetherepicardium-derived cellswill invade the
myocardium or remain sub-epicardial are unknown.
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implicated in coronary vascular development: FGFR-1 and -2 signaling
in cardiomyocytes is required for activation of hedgehog-dependent
pathways controlling coronary vasculogenesis (Lavine et al., 2006). It
remains unclear, however, if FGFR-1 signaling in epicardial cells is
required for EMT, myocardial invasion, and coronary vessel formation.
Recent studies on zebraﬁsh reveal an important role for myocardial
expression of FGF ligand and FGFR signaling for epicardial EMT and
subsequent invasion of the myocardium during regeneration after
surgical resection, and in normal homeostasis and maintenance of the
adult heart (Lepilina et al., 2006; Wills et al., 2008). In the former
study, it was shown that FGFR-2 and -4 were up-regulated in the
epicardium upon heart damage, but the contribution of FGFR-
mediated signaling in the myocardium toward repair remains unclear
as the transgenic approach inhibited FGFR-mediated signaling in all
cardiac tissues (Lepilina et al., 2006).
Other key steps in the formation of the coronary vasculature
include the determination and differentiation of vascular lineages,
including endothelial and smooth muscle cells. Lineage tracing of
coronary vessel precursors in the chick embryo using replication-
defective retroviral vectors expressing a reporter gene demonstrated
that the coronary endothelial, smooth muscle and adventitial cell
lineages have already segregated at the PE stage (Mikawa and
Fischman, 1992; Mikawa and Gourdie, 1996). The extent of their
commitment, however, has not been experimentally addressed.
Numerous angiogenic and vasculogenic factors have been identiﬁed,
including the FGF family. FGFs are capable of stimulating angioblast
formation, the earliest stage of vascular induction (Poole et al., 2001;
Vokes and Krieg, 2002), and have long been implicated in other
aspects of vascular development, being able to act directly on vascular
cells, affecting vessel induction, and formation (for reviews, see
Flamme et al., 1997; Folkman and D'Amore, 1996; Presta et al., 2005;
Slavin, 1995). FGF expression in the myocardium has an effect on
coronary vessel formation through paracrine signaling (Fernandez et
al., 2000; Tomanek et al., 1998), and has a role patterning the
intramural capillary network (Pennisi and Mikawa, 2005). In addition,
ectopic over-expression of FGFs in PE cells promotes the formation
and branching of coronary blood vessels in an autocrine manner (Hyer
et al., 1999).
Most FGF effects are mediated through the FGFRs in numerous cell
types, including developing vascular cells (reviewed in Powers et al.,
2000; Presta et al., 2005). FGFRs are expressed dynamically and can be
up-regulated in response to FGF (Estival et al., 1996; Saito et al., 1991).
Moreover, epicardium-derived cells up-regulate FGFR-1 expression in
response to myocardial over-expression of FGF (Pennisi and Mikawa,
2005). Thus, there is evidence indicating a role for FGFR-mediated
signaling in different stages of epicardial and coronary vascular
development. We hypothesised that FGFR-1 signaling plays a key role
in epicardial EMT and coronary vasculature development. This was
tested by modulating FGFR-1 levels in epicardial and coronary
precursors in the PE with replication-defective retroviral vectors to
over-express or knock-down receptor levels. Over-expression of FGFR-
1 in PE progeny resulted in increased epicardial EMT. Knock-down of
FGFR-1, however, did not reduce epicardial EMT but greatly compro-
mised the ability of PE progeny to invade the myocardium. PE progeny
with knock-down of FGFR-1 were able to invade the sub-epicardium
and express endothelial and smoothmusclemarkers and contribute to
the sub-epicardial coronary vasculature. At E12, there was an
increased proportion of coronary endothelial cells amongst FGFR-1
over-expressing PE progeny, while there was a decreased proportion
of coronary smoothmuscle in PE progeny with knock-down of FGFR-1.
In cultured PE explants, FGF2 induced EMT whilst FGFR antagonism
inhibited EMT. Furthermore, FGF2 modestly promoted endothelial
differentiation whilst FGFR antagonism decreased smooth muscle
differentiation. Finally, upon constitutive activation of FGFR-1, more
epicardial cells invaded the sub-epicardium and myocardium inwhole-heart explant cultures. Thus, FGFR-1 signaling can promote
epicardial EMT; is essential for invasion of the myocardium by PE
progeny; and inﬂuences coronary lineage differentiation.
Materials and methods
Embryos
Fertilized quail eggs were purchased from CBT Farms (Chester-
town, Maryland) and incubated at 38 °C under humidiﬁed conditions.
Embryos were staged according to the number of days incubated or by
the system of Hamburger and Hamilton (Hamburger and Hamilton,
1951).
Immunohistochemistry and immunoﬂuorescence
Whole embryos or embryonic hearts were dissected in phosphate-
buffered saline (PBS), ﬁxed in 2% paraformaldehyde (PFA) in PBS at
4 °C for 2–4 h, dehydrated in an ethanol series, cleared in CitriSolv
(Fisher Scientiﬁc, USA), and embedded in parafﬁn. Serial, 7 μm,
transverse sections were cut and mounted on Superfrost slides (VWR,
USA). Immunohistochemistry was performed as described (Pennisi et
al., 2003) with the following antibodies: anti-FGFR-1 (sc-15, Santa
Cruz Biotechnology), QH1 (Developmental Studies Hybridoma Bank,
The University of Iowa), anti-cytokeratin (BT-571, Biomedical Tech-
nologies), anti-SMαA (clone 1A4, Sigma). Some sections were
counterstained with nuclear fast red to aid quantiﬁcation. Indirect
immunoﬂuorescence using the QH1 and anti-FGFR-1 antibodies was
performed on sections prepared as above. Sections were blocked in 2%
BSA in PBS/0.1% Tween 20 and incubated with primary antibodies.
Sections were then washed in PBS and incubated with Alexa Fluor
488- and Alexa Fluor 594-conjugated secondary antibodies (Mole-
cular Probes). After washing in PBS, slides were mounted with
Vectashield Mounting Medium (Vector Laboratories).
In ovo injection of retroviruses and sample analyses
High titre preparations (107–108 plaque forming units/mL) of
replication-defective retroviruses were prepared and pressure-
injected in ovo into the PE of HH17–18 embryos to infect epicardial
and epicardial derived cells as previously described (Fig. 2; Hatcher et
al., 2004; Hyer et al., 1999; Mikawa and Gourdie, 1996). The retroviral
vectors employed in this study have been described previously: CXL
(expressing β-galactosidase; Mikawa et al., 1991, 1992), SNFRIZ
(expressing chick FGFR-1 and β-galactosidase from a di-cistronic
mRNA; Itoh et al., 1996; Mima et al., 1995), and SNαFRIZ (expressing
antisense FGFR-1 and β-galactosidase from a di-cistronic mRNA; Itoh
et al., 1996; Mima et al., 1995). The effective expression and biological
activity of FGFR-1 from SNFRIZ and knock-down of FGFR-1 from
SNαFRIZ have been shown previously (Itoh et al., 1996; Mima et al.,
1995). Hearts were dissected at embryonic days (E) 7, E10, and E12 in
PBS, ﬁxed in 2% PFA in PBS at 4 °C for 2–4 h, and stained with X-Gal at
37 °C overnight. After numerous washes in PBS and whole-mount
photography, samples displaying X-Gal staining were embedded in
parafﬁn and processed for immunohistochemistry as described above
or counterstained with nuclear fast red. For quantiﬁcation of virus-
infected PE progeny at E7 and E12, all X-Gal+ cells from sectioned
hearts were scored as set out in Supplemental Table 1 (generally after
immunohistochemistry with the QH1 or anti-SMαA antibodies). A
minimum of three hearts displaying X-Gal staining for each viral
vector, at each developmental stage, was used for quantiﬁcation of cell
fate. The data in Supplemental Table 1 are further summarized in Fig. 5
to show the percentage of X-Gal+ PE progeny that (i) remained in the
epicardium, (ii) occupied an intra-myocardial location (intra-atrial or
intra-ventricular), (iii) were QH1-immunoreactive or (iv) were anti-
SMαA-immunoreactive. When expressing the percentage of PE-
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atrial, atrio-ventricular and ventricular components of the heart were
considered, not adventitial regions around the great vessels or
truncus/OFT.
Proepicardial explant cultures
PE of stage HH16–17 quail embryos were isolated using ﬁne
dissecting forceps in PBS/0.05% BSA to prevent tissue from adhering to
the plastic dishes. They were then cultured in serum-free DMEM
supplemented with penicillin and streptomycin for 16 h and allowed
to attach to ﬁbronectin-coated coverslips. The media was then
replaced with fresh serum-free DMEM (−FCS) or DMEM supplemen-
ted with 10% fetal calf serum (+FCS); FGFR inhibitor (SU5402; Merck);
0.1% DMSO; 10 ng/mL or 50 ng/mL FGF2 (1104616, Roche Diagnostics);
or 1 ng/mLTGFβ2 (302-B2-002, R&D Systems). Explants were cultured
for a further 5 days, ﬁxed in 4% PFA and processed for immuno-
ﬂuorescence (with anti-SMαA or QH1 antibodies) and DAPI staining.
Low magniﬁcation images were captured such that entire explants
were photographed. DAPI-stained nuclei and immunoﬂuorescent cellsFig. 1. FGFR-1 expression is spatially and temporally restricted in the PE and epicardium-deri
L, E5. QH1 immunohistochemical detection of vascular endothelia and their precursors (A, B,
G, respectively. Comparable regions were stained for FGFR-1 immunoreactivity (C, F, I a
immunoreactive for QH1 or FGFR-1. Also note, at E6, sub-epicardial cells are more strongly FG
and FGFR-1 (green) at E5 showing a sub-epicardial cell immunoreactive for both antibodies
100 μm.were quantiﬁed with ImageJ software (NIH; http://rsb.info.nih.gov/ij/)
or manually using Adobe Photoshop software (version 7.0, Adobe
Systems Inc.). At least four explants for each culture condition and
antibody staining were examined and the mean percentage of
immunoreactivity calculated.
Construction of a constitutively activated FGFR-1
To constitutively activate FGFR-1-mediated signaling pathway in
epicardial cells, we used a derivative of human FGFR-1, myrR1-TDII
(Hart et al., 2000). This clone consists of the cytoplasmic domain of
human FGFR-1 with a Lys656NGlumutation in the activation loop and
a myristylation signal to target the protein to the plasma membrane.
This has been shown to phosphorylate STAT1, STAT3 and p44/42
MAPK, components of the FGFR-mediated signaling pathway (Hart et
al., 2000). This modiﬁed FGFR-1 cDNA was cloned into the proviral
vector, pCXIZ (Mikawa et al., 1991), upstream of an IRES and LacZ
sequence, and termed pCAFR-1. To conﬁrm the ability of the pCAFR-1
construct to activate components of the FGFR-mediated signaling
pathway, the levels of STAT1, STAT3 and p44/42 phosphorylationwereved cells, and in some vascular endothelial precursors. A–C, E3; D–F, E4; G–I, E5; J, K, E6;
D, E, G, H and J). B, E and H are higher magniﬁcation views of the boxed areas in A, D and
nd K). Note the cells (arrows) and putative lumen structures (arrowheads) that are
FR-1+ than are epicardial cells (arrows, K). (L) Double immunoﬂuorescence for QH1 (red)
(arrow). en, endocardium; ep, epicardium; my, myocardium; tr, trabeculae. Scale bars,
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were transiently transfected with pCAFR-1 or pCXIZ. Cells were
stained with X-Gal to gauge transfection efﬁciency or used for
preparation of whole-cell lysate that was separated by SDS-PAGE
and transferred to nitrocellulose membranes. Immunoblotting was
performed as described (Hart et al., 2000), using the commercial
antibodies described therein. Immunoblotting data are representative
examples of three transfections.
Explant invasion assay
Freshly dissected E6 hearts were transferred to electroporation
cuvettes (5 mm gap) containing 40 μg of pCXIZ (encoding β-
galactosidase) or pCAFR-1 (encoding β-galactosidase and a constitu-
tively activated FGFR-1) in 110 μL PBS. Constructs were introduced into
epicardial cells by electroporation (5 pulses of 30 ms at 60 V). After
incubation on ice for 5 min, hearts were cultured in serum-free DMEM
supplemented with penicillin and streptomycin in BSA-coated tissue
culture dishes to avoid adherence of the explanted tissue. After 48 h,
hearts were processed for X-Gal staining and parafﬁn embedding as
above. In all cases, explanted hearts maintained a rhythmic heartbeat
and remained unattached to the tissue culture dishes during
incubation. 10 μm coronal sections were cut on a microtome and
processed for nuclear fast red counterstaining. For quantiﬁcation of
epicardial EMT and invasion, only X-Gal-positive cells in the
ventricular component of the explant with a clearly stained nucleus
were counted and scored for their location (epicardial, sub-epicardial,
or intra-myocardial). Every third sectionwas used for quantiﬁcation to
avoid counting the same cell more than once. The relative proportions
of epicardial, sub-epicardial or intra-myocardial X-Gal+ cells were
expressed as a percentage of total X-Gal+ cells counted from that
explant. At least three explants of each type were examined and the
mean and standard deviation of the mean calculated. In addition to
nuclear fast red counterstaining, some sections were stained for
immunoreactivity with a phospho-p44/42 MAPK-speciﬁc antibody
(Cell Signaling Technology, #4376) according to the manufacturers
speciﬁcations.Fig. 2. Experimental procedure for retroviral targeting epicardial and coronary vascular pr
(FGFR-1 and β-galactosidase) and SNαFRIZ (antisense FGFR-1 and β-galactosidase) were inje
hearts X-Gal-stained at E7, E10, and E12, respectively. High magniﬁcation views are of the box
structures (arrows). (E) Cytokeratin immunostaining of an E10 heart injected with control
injected with control virus showing labelling of smooth muscle cells of a coronary artery. (G
coronary artery endothelia. (H) QH1 immunostaining of an E12 heart injected with controlData documentation
Images were captured using either a Digital Photo Camera (DKC-
5000, Sony) or a Spot RT Slider (2.3.1, Diagnostic Instruments Inc.,
USA) using Adobe Photoshop software (version 7.0, Adobe Systems
Inc.) or Spot (version 3.2.6 Diagnostic Instruments Inc, USA) software,
respectively. Images were adjusted for color levels, brightness and
contrast, and ﬁgures compiled, using Adobe Photoshop software.
Statistical analyses
Statistical signiﬁcance of the difference in the fate of FGFR-1 and
antisense FGFR-1 virus-infected proepicardial cells relative to control
data was determined using the Chi-square test. For proepicardial
explant cell phenotype and epicardial invasion in heart explants,
statistical signiﬁcance was determined using an unpaired two-tailed
Student's t test.
Results
FGFR-1 is expressed in a subset of PE and epicardium-derived cells
including endothelial precursors
As FGFs have been implicated in numerous aspects of heart
development, including formation of the coronary vasculature, we
examined the expression of FGFR-1 in the population of cells that give
rise to the coronary vasculature from the stage when the PE is forming
and contacting the tubular heart (∼E3 in the quail embryo). In parallel,
we used the QH1 antibody, a marker for quail endothelial cells and
their precursors (Pardanaud et al., 1987). In addition, non-immune
serum controls were conducted. At no stage was non-speciﬁc signal
detected (not shown). At E3, QH1+ cells are present in the PE that
bridges the dorsal body wall and the myocardium of the tubular heart
(Figs. 1A, B). Likewise, FGFR-1+ cells were observed in the PE (Fig. 1C).
At E4 and E5 (Figs. 1D–I), a similar distribution of QH1+ and FGFR-1+
cells was observed in the primitive epicardium and sub-epicardium.
At E6, a stage when the epicardium has almost enveloped the entireecursors in the quail embryo. (A) The retroviral vectors, CXL (β-galactosidase), SNFRIZ
cted into the PE (shown in blue) of quail embryos. (B–D)Whole-mount views of control
ed areas in insets. Note X-Gal+ cells amongst the epicardium (arrowheads) and vascular
virus showing labelling of the epicardium. (F) SMαA immunostaining of an E12 heart
) QH1 immunostaining of an E12 heart injected with control virus showing labelling of
virus showing labelling of intramural coronary endothelia. Scale bars, 20 μm.
Fig. 3. Test virus-infected hearts X-Gal-stained at E7. An example of an FGFR-1 virus-infected heart (A–D) and an antisense FGFR-1 virus-infected heart (E–F) at E7. (A) Whole-mount
view showing X-Gal+ cells close to the surface of the heart (boxed area of inset). (B) QH1 immunostaining on a transverse section at the level of the outﬂow tract. (C) Higher
magniﬁcation view of the boxed area in B showing X-Gal+/QH1+ cells (arrows). (D) QH1 immunostaining at the level of the ventricle showing an X-Gal+/QH1+ cell in the sub-
epicardium (arrow). (E) Whole-mount view showing X-Gal+ cells close to the surface of the heart (boxed area of inset). (F) QH1 immunostaining at the level of the outﬂow tract.
(G) Highermagniﬁcation viewof the boxed area in F. Note the X-Gal+/QH1+ cell (arrow). (H) SMαA immunostaining of an adjacent section to that shown inG showing anX-Gal+/SMαA−
cell (arrow). Scale bars, 20 μm.
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evident in the sub-epicardium, appearing as isolated cells and in
lumenised structures (Fig. 1J). At this stage, sub-epicardial cells are
more strongly FGFR-1-immunoreactive than epicardial cells (Fig. 1K).
At the stages examined, we observed comparatively large, round,
QH1+ cells, presumably angioblasts (Pardanaud et al., 1987; Poole etFig. 4. Test virus-infected hearts X-Gal-stained at E12. Examples of FGFR-1 virus-infected he
mount view showing X-Gal+ cells in coronary vessels (boxed area of inset). (B) View of the
vessels (arrows). (C) Whole-mount view of another FGFR-1 virus-infected heart showing X-G
antisense FGFR-1 virus-infected heart showing X-Gal+ cells in a vascular structure (arrows
immunostaining of a section of the heart shown in A and B revealing an X-Gal+ cell luminal to
of an adjacent section to that shown in E, showing X-Gal+/QH1+ cells (arrows). (G) SMαA im
revealing X-Gal+/SMαA+ cells in the media of a coronary artery (arrows). Note X-Gal+ cells tha
(H) QH1 immunostaining on a section of the heart shown in D showing an X-Gal+/QH1+ cell
revealing X-Gal+ cells in the sub-epicardium (arrowheads) and amongst the smooth muscleal., 2001). The overlap of QH1 and FGFR-1 immunoreactivity, for at
least a proportion of epicardium-derived cells, was demonstrated at
E5 (Fig. 1L). Consistent with previous reports, FGFR-1 expression was
observed in cardiomyocytes (Patstone et al., 1993; Pennisi et al., 2003).
It was, therefore, difﬁcult to examine FGFR-1 expression amongst
coronary progenitors that had invaded the myocardium. Examiningarts (A–C, E–G) and an antisense FGFR-1 virus-infected heart (D, H, I) at E12. (A) Whole-
left ventricle of the heart shown in A. X-Gal+ endothelial cells are present in coronary
al+ cells amongst a vascular structure (boxed area of inset). (D) Whole-mount view of an
) and the epicardium or sub-epicardium (arrowheads; boxed area of inset). (E) SMαA
the presumptivemedia (SMαA+) of a coronary vessel (arrow). (F) QH1 immunostaining
munostaining of a section of the heart shown in C at the level of the boxed area of inset
t do not appear to be part of the media, but rather adventitia or ﬁbroblasts (arrowhead).
associated with a sub-epicardial vessel. (I) SMαA immunostaining of a nearby section,
of a sub-epicardial arteriole (arrow). Scale bars, 20 μm.
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allowed us to assess the relative FGFR-1 immunoreactivity before such
progenitors invaded the myocardium. Thus, at the different stages
examined, FGFR-1 was expressed in a spatially restricted manner
amongst primitive epicardial and sub-epicardial cells, the population
of cells that include coronary vascular progenitors. Furthermore, sub-
epicardial cells expressed FGFR-1 at levels higher than epicardial cells,
suggestive of it having a role in EMT and invasion.
Modulation of FGFR-1 levels in PE cells affects epicardial EMT,
myocardial invasion and coronary lineage differentiation
We tested the role of FGFR-1 in epicardial EMT and invasion, and
for coronary cell differentiation, by modulating FGFR-1 levels in
epicardial and coronary vessel precursors. Replication-defective
retroviral vectors were injected into the PE of quail embryos in ovo
at HH17–18 (∼E3); CXL, expressing β-galactosidase; SNFRIZ, expres-
sing chick FGFR-1 and β-galactosidase; and SNαFRIZ, expressing
antisense FGFR-1 and β-galactosidase (Fig. 2A; Itoh et al., 1996;
Mikawa et al., 1991; Mima et al., 1995). The efﬁcacy of PE injections in
quail embryos was determined using control virus. Hearts dissected at
E7, E10, and E12 regularly displayed X-Gal+ cell clusters reminiscent of
epicardial and coronary vascular colonies (Figs. 2B–D; Mikawa and
Fischman, 1992; Mikawa and Gourdie, 1996). Immunohistochemistry
for cytokeratin (a marker for epicardial cells; Vrancken Peeters et al.,
1995), smooth muscle α actin (SMαA) and QH1 were used to
determine cellular identity. We found X-Gal+ cells amongst theFig. 5. Summary of the fate of control, FGFR-1, and antisense FGFR-1 virus-infected proepicard
hearts in each category is in parentheses. Note the increase in the proportion of QH1+ cells in
in the proportion of SMαA+ cells in antisense FGFR-1 virus-infected hearts. (B) The fate of v
X-Gal+ cells in antisense FGFR-1 virus-infected hearts. As at E7, an increase in the proportion
although the proportion for antisense FGFR-1 virus-infected hearts was similar to controls.
infected samples. At both E7 and E12, in FGFR-1 virus-infected hearts there was almost a
antisense FGFR-1 virus-infected hearts. †, expressed as a percentage of all X-Gal+ cells fro
Materials and methods). ⁎P valueb0.05; ⁎⁎P valueb0.001.epicardium, coronary artery smooth muscle, coronary artery endothe-
lial cells and intramural, capillary endothelial cells (Figs. 2E–H). This
indicated epicardial and coronary precursors were successfully
targeted by PE injection as described for the chick embryo (Hatcher
et al., 2004; Hyer et al., 1999; Mikawa and Gourdie, 1996).
Next, FGFR-1 levels were modulated in PE cells and their progeny
using either the FGFR-1 or the antisense FGFR-1 viruses. Embryos
were allowed to develop until E7 or E12 before X-Gal staining and
section immunohistochemistry. At E7, in FGFR-1 virus-infected hearts
we observed numerous X-Gal+/QH1+ and X-Gal+/SMαA− cells around
the outﬂow tract (OFT) and sub-epicardium at the level of the
ventricles (Fig. 3). Many of these, particularly around the OFT,
appeared as large, round isolated cells, probably representing
angioblasts. Likewise, in antisense FGFR-1 virus-infected hearts at
E7, numerous QH1+/SMαA− cells were observed around the OFT. At
E12, X-Gal+ structures were frequently observed in stained virus-
infected hearts viewed in whole-mount similar to virally tagged
epicardial and sub-epicardial cells, and portions of coronary vessels as
described previously (Hatcher et al., 2004; Mikawa and Fischman,
1992; Mikawa and Gourdie, 1996). An example where X-Gal+ cells are
arranged along the axes of vessels, indicative of endothelia, is shown
(Figs. 4A, B; Mikawa and Fischman, 1992). Immunostaining showed
these to be luminal, QH1+ and SMαA−, conﬁrming their endothelial
identity (Figs. 4E, F). Also observed were X-Gal+ cells arranged spirally
with their axis transverse to that of the vessel (Fig. 4C). Section
immunostaining showed these to be SMαA+. In addition, X-Gal+/
SMαA− cells were observed in close proximity to the X-Gal+ smoothial cells. (A) The fate of virus-infected cells at E7. The total number of X-Gal+ cells from all
FGFR-1, and antisense FGFR-1 virus-infected hearts relative to controls, and the increase
irus-infected cells at E12. Note the marked decrease in the number of intra-myocardial
of QH1+ cells in FGFR-1 virus-infected hearts relative to controls was observed at E12,
Also note the decrease in proportion of X-Gal+/SMαA+ cells in antisense FGFR-1 virus-
complete reduction in X-Gal+ cells resident in the epicardium relative to control and
m the atrial, atrio-ventricular and ventricular components of the heart (described in
Fig. 6.Modulating FGF signaling affects EMTand endothelial and smoothmuscle cell phenotype in PE explant culture. A PE immediately after dissection (A) and one that has formed a
monolayer after 36 h of culture (B). (C) Higher magniﬁcation of the leading edge of PE explantmonolayers after 3 days of culture in the presence of factors as indicated. The cells at the
leading edge of explants cultured in the presence of FGFR inhibitor maintained an epithelial phenotype. Examples of cultured PE explants displaying QH1 and DAPI staining (D) and
SMαA and DAPI staining (E). (F) Quantiﬁcation of QH1 and SMαA immunoreactivity after 5 days of various culture conditions. Therewas a reduction in the percentage of SMαA+ cells
in PE cultured with FGFR inhibitor relative controls. In addition, there was a modest increase in the percentage of QH1+ cells in PE treated with FGF2 (50 ng/mL). Under all conditions
except TGFβ2 treatment there was a signiﬁcant difference between the numbers of QH1+ and SMαA+ cells (P valueb0.02). Error bars, standard deviation of the mean. ⁎P valueb0.1;
⁎⁎P valueb0.05. Scale bars; A and B, 200 μm; C, 100 μm; D and E, 50 μm.
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155D.J. Pennisi, T. Mikawa / Developmental Biology 328 (2009) 148–159muscle cells (Fig. 4G). In antisense FGFR-1 virus-infected hearts at E12,
X-Gal+ vascular structures were also observed, but only superﬁcially
on the heart (Fig. 4D). Section analysis revealed both X-Gal+/SMαA+
and X-Gal+/QH1+ cells associated with the coronary vasculature (Figs.
4H, I). Importantly, these were rarely found in the ventricular or atrial
myocardium. Thus, antisense FGFR-1 virus-infected PE progeny were
able to express endothelial or smooth muscle markers and contribute
to the coronary vasculature, but only in the sub-epicardium.
The quantiﬁcation of fate and location of all X-Gal+ cells in virus-
infectedhearts in this studyaredetailed in Supplemental Table 1. These
datawere summarized to highlight the percentage of X-Gal+ cells at E7
and E12 that were; (i) epicardial, (ii) intra-myocardial, (iii) QH1+ or (iv)
SMαA+ (Fig. 5). At E7 in controls, 7.3% of X-Gal+ cells were epicardial,
13.0% were sub-epicardial, and 79.7% were in the truncus/OFT region.
No X-Gal+ cells were found in the adventitia around the OFT and atria.
In FGFR-1 virus-infected hearts at E7, however, no X-Gal+ epicardial
cells were observed. 2.3% of X-Gal+ cells were sub-epicardial, 89.7%
were in the truncus/OFT region, and 8.0% were in the adventitia
around the OFT and atria. In antisense FGFR-1 virus-infected hearts at
E7, 3.8% of X-Gal+ cells were epicardial, 45.3% were sub-epicardial,
34.6% were in the truncus/OFT region, and 16.4% in the adventitia
around the OFT and atria. In controls at E12, 8.3% of all X-Gal+ PE-
derived cells were epicardial while 47.4% of X-Gal+ cells from the
atrial, atrio-ventricular and ventricular components of the heart were
in intra-myocardial locations. In FGFR-1 virus-infected hearts, how-
ever, a marked reduction in X-Gal+ epicardial cells was observed
(0.1%), with an increase in intra-myocardial relative to controls
(51.4%). In antisense FGFR-1 virus-infected hearts, a decrease in X-Gal+
epicardial cells was observed (3.8%), however, we found a dramatic
reduction in the number of PE-derived X-Gal+ cells located in the
myocardium (0.2%). Thus, there was a concomitant increase in the
proportion of X-Gal+ cells that were sub-epicardial (ventricular and
atrio-ventricular regions of the heart) by E12 in FGFR-1 virus-infected
hearts (31.3% of all X-Gal+ cells) and antisense FGFR-1 virus-infected
hearts (58.9%) relative to controls (14.1%). There was, however, a
decrease in the proportion of X-Gal+ cells residing in the adventitia
around the great vessels and atria in FGFR-1 virus-infected hearts
(35.3% of all X-Gal+ cells) and antisense FGFR-1 virus-infected hearts
(37.2%) relative to controls (57.6%) at E12.
In controls at E7,18.4% ofX-Gal+, PE-derived cellswereQH1+. FGFR-1
and antisense FGFR-1 virus-infected hearts both displayed an increase
in X-Gal+/QH1+, PE-derived cells (99.1% and65.4%, respectively). At E12,
theproportion ofX-Gal+/QH1+, PE-derived cells in controlswas 26.0%. A
value similar to controls was observed in antisense FGFR-1 virus-
infected hearts (26.8%), although these cells were in different locations
in the heart. In FGFR-1 virus-infected hearts at E12, however, an
increase in the proportion of X-Gal+/QH1+ cells was observed (42.3%).
At E7, we did not detect any X-Gal+/SMαA+, PE-derived cells in control
or FGFR-1 virus-infected hearts. In antisense FGFR-1 virus-infected
hearts, however, 18.5% of X-Gal+, PE-derived cells were SMαA+. At E12,
in control and FGFR-1 virus-infected hearts, 37.5% and 34.6% of X-Gal+,
PE-derived cells were SMαA+, respectively. By contrast, 19.5% were
SMαA+ in antisense FGFR-1 virus-infected hearts.
Thus, over-expression of FGFR-1 in PE cells resulted in an increase
in the proportion of QH1+ cells. At E7, knock-down of FGFR-1 in PE
cells also resulted in an increase in the proportion of QH1+ cells,
although by E12 the proportion was similar to controls. Similarly,
knock-down of FGFR-1 also resulted in an increase in the proportion of
SMαA+ cells at E7, although by E12 there was a reduction relative to
controls. Strikingly, over-expression of FGFR-1 in PE progeny resulted
in a decreased ability to remain epicardial. Knock-down of FGFR-1,
however, compromised the ability of epicardial cells to invade the
myocardium and contribute to intramural vessels, although they were
able to undergo EMT and invade the sub-epicardium. They were also
able to express endothelial and smooth muscle markers and
contribute to sub-epicardial vessels.Modulating FGF signaling affects EMT and coronary lineage
differentiation in cultured PE explants
To further investigate the role of FGFR-mediated signaling in EMT
of the epicardial mesothelium, as well as vascular phenotype
differentiation, we utilized a PE explant culture system. Once
explanted, isolated PE formed epithelial sheets in culture (Figs. 6A,
B) and co-expressedWT-1, cytokeratin, and vimentin, characteristic of
the epicardial mesothelium (data not shown). To experimentally
modulate cellular phenotype in cultured PE explants, media was
supplemented with FGF2 or a pharmacological inhibitor of FGFR
signaling, SU5402. TGFβ2 was used as a positive control for epicardial
EMT (Compton et al., 2006; Dokic and Dettman, 2006). After 3 days of
culture, cells at the leading edge of explants cultured with FGF2
(10 ng/mL and 50 ng/mL) or TGFβ2 were more likely to be separated
from the main explant and ﬁbroblast-like in appearance than in
control explants. Cells at the leading edge of PE explants cultured with
FGFR inhibitor, however, were less likely to adopt a ﬁbroblast-like
appearance and more likely to remain part of the main explant and
retain an epithelial phenotype (Fig. 6C). Similar to earlier time points,
PE cultured in the presence of TGFβ2 or FGF2 for 5 days showed more
isolated cells than those cultured in the presence of fetal calf serum or
FGFR inhibitor (Supplemental Fig. 1). After 5 days of culture, the
number of ﬁbroblast-like cells in explanted PE increased under all
conditions.
To further examine the effect of FGFR signaling on coronary lineage
differentiation, PE explants were cultured with exogenous FGF2, FCS,
TGFβ2 or FGFR inhibitor. After 5 days, explants were stained with QH1
or anti-SMαA antibodies and the number of immunoreactive cells
quantiﬁed (Figs. 6D–F). The percentage of SMαA+ cells in PE explants
were: 44.3% for −FCS, 49.3% for +FCS, 48% for FGF2 (10 ng/mL), 51.4%
for FGF2 (50 ng/mL), 39.6% for TGFβ2 (1 ng/mL), 64.4% for DMSO
(carrier control), and 45% for FGFR inhibitor. QH1 immunoreactivity
amongst PE explants were: 10.9% for −FCS, 15.8% for +FCS, 19% for
FGF2 (10 ng/mL), 23.7% for FGF2 (50 ng/mL), 25.7% for TGFβ2 (1 ng/
mL), 13.6% for DMSO, and 22.7% for FGFR inhibitor (Fig. 6F). We
observed a signiﬁcant reduction in the percentage of SMαA+ cells in PE
cultured with FGFR inhibitor (45%) relative to controls (64.4%). In
addition, there was a modest increase in the percentage of QH1+ cells
in PE treated with FGF2 (50 ng/mL; P valueb0.1). Under all culture
conditions except TGFβ2 treatment, there were signiﬁcantly more
SMαA+ cells (44.3–64.4%) than QH1+ cells (10.9–23.7%) amongst
explants (P valueb0.02). The data show that FGF and FGFR signaling
promote EMT in PE explants. Moreover, exogenous FGF and an
inhibitor of FGFR signaling can affect coronary lineage differentiation
in cultured PE. Together with the changes in the proportion of QH1+
and SMαA+ cells amongst virus-infected PE progeny, the data
demonstrate that FGFR-mediated signaling modulates coronary
vascular lineage differentiation.
Constitutive activation of FGFR-1-mediated signaling pathway in
epicardial cells increases invasiveness
The lineage tracing data of virus-infected PE progeny indicated that
FGFR-1 expression was sufﬁcient but not necessary to induce
epicardial EMT. FGFR-1 expression did, however, appear necessary
for epicardium-derived cells to invade the myocardium. It remained
unclear, however, whether activation of the FGFR-1 signaling pathway
was sufﬁcient for epicardial cells to invade the sub-epicardium and
the myocardium. To test this, we used a construct encoding β-
galactosidase and a constitutively activated FGFR-1, pCAFR-1, based on
the pCXIZ proviral construct encoding β-galactosidase alone (Hart et
al., 2000; Mikawa et al., 1991). We conﬁrmed pCAFR-1 activated
components of the FGFR-1 pathway in the D17.2G cell line: Compared
to pCXIZ-transfected cell lysate, pCAFR-1-transfected cell lysate had
elevated levels of phospho-p44/42 MAPK, phospho-STAT1, and
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al., 2000). These constructs were then applied to a heart explant
system where they were introduced into epicardial cells by electro-
poration.We found that pCAFR-1-transfected cells were more likely to
have anti-phospho-p44/42MAPK-immunoreactive nuclei than pCXIZ-
transfected cells, indicating that pCAFR-1 activated the FGFR-1signaling pathway in epicardial cells (Figs. 7C–F). Quantiﬁcation of
X-Gal+ cells in the ventricular component of pCXIZ-transfected hearts
revealed that 57.4% were epicardial, 41.1% were sub-epicardial, and
1.5% were intra-myocardial (Fig. 7K). This is consistent with previous
reports using epicardial invasion assays showing that the majority of
cells remained epicardial (Dettman et al., 2003; Dokic and Dettman,
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resulted in 22.3% of X-Gal+ cells remaining epicardial, 62.2%, sub-
epicardial, and 15.5% intra-myocardial (Fig. 7K). Relative to controls,
epicardial cells expressing pCAFR-1 were less likely to remain
epicardial and more likely to occupy either the sub-epicardium or
the myocardium (P valueb0.005). Thus, constitutively activating the
FGFR-1 signaling pathway in epicardial cells increased their propen-
sity to undergo EMT and invade both the sub-epicardium and the
myocardium.
Discussion
A number of factors have been identiﬁed that are involved in
epicardial EMT, including FGFs and TGFβs that can promote EMT
(Compton et al., 2006; Morabito et al., 2001) and integrin α4 and
VCAM-1 that inhibit EMT (Dettman et al., 2003; Dokic and Dettman,
2006). Studies have also implicated FGFR signaling in epicardial EMT
in adult zebraﬁsh hearts (Lepilina et al., 2006; Wills et al., 2008).
FGFR-1 and -2 signaling in coronary endothelial cells were reported to
be dispensable for coronary development in mouse embryos based on
conditional deletion driven by Tie1-Cre and Flk1-Cre (Lavine et al.,
2006). It remains a possibility that FGFR-1 or -2 signaling may have
had a role before Flk1-Cre and Tie1-Cre are expressed at levels
necessary to complete the Cre-mediated recombination. Furthermore,
it remains unclear whether FGF expression is affected upon disruption
of FGFR-1 and -2 in cardiomyocytes. In this study, we utilized
replication-defective retroviral vectors in the avian embryo to better
understand the function of FGFR-1 in epicardial and coronary vascular
development.
FGFs and FGFRs are involved in many aspects of cardiovascular
development, including the speciﬁcation and differentiation of various
lineages through both paracrine and autocrine mechanisms (Poole et
al., 2001; Presta et al., 2005; Slavin, 1995). Cardiomyocyte-expressed
FGFs have an autocrine effect and a paracrine effect on coronary
vascular cells (Fernandez et al., 2000; Mima et al., 1995; Pennisi and
Mikawa, 2005; Tomanek et al., 1998). FGF signaling has also been
implicated in cardiovascular pathology, as well as being the subject of
research for therapeutic intervention (Molin and Post, 2007; Syed et
al., 2004). We further deﬁned the role of FGFR-1 in epicardial EMT and
identiﬁed a requirement upon FGFR-1 for myocardial invasion by
epicardium-derived cells. We show that over-expression of FGFR-1
promotes EMT from the epicardium, but is not necessary for EMT as
antisense FGFR-1 virus-infected epicardial cells can occupy the sub-
epicardium. Therefore, a receptor other than FGFR-1 may play a
redundant role in epicardial EMT during development, although such
roles for other FGFRs remain to be determined. What have not been
identiﬁed previously are the factors that determine whether epicar-
dium-derived cells will remain in the sub-epicardium or invade the
myocardium. Here, we show that FGFR-1 expression in epicardium-
derived cells is important for their ability to invade the myocardium
and contribute to the intramural vasculature. In this particular
process, it appears FGFR-1 plays a non-redundant role. Identiﬁcation
of a role for FGFR-1 provides a starting point for investigation into
what other factors are required for epicardium-derived cells to invade
the myocardium.Fig. 7. Constitutive activation of the FGFR signaling pathway in epicardial cells increases
(constitutively activated FGFR-1 and β-galactosidase); examples of D17.2G cells X-Gal stained
D17.2G whole-cell lysate transiently transfected with either pCXIZ or pCAFR-1. In addition
2000). Also note the relative increase in the levels of phospho-p44/42 MAPK, phospho-STA
processed for X-Gal staining and anti phospho-p44/42 MAPK immunohistochemistry. (C,
explants. pCAFR-1-transfected cells were more likely to have anti-phospho-p44/42-immuno
processed for X-Gal staining and histology. (G, H) Examples of pCXIZ-transfected explants. (I,
sub-epicardial (arrowheads, H) locations of X-Gal+ cells from pCXIZ-transfected heart exp
epicardial (arrowhead, J) locations of X-Gal+ cells from pCAFR-1-transfected heart explants
localization of X-Gal+ cells; grey bars, sub-epicardial localization; open bars, intra-myocardia
transfected values relative to pCXIZ-transfected values. Scale bars; C, 10 μm; G, 5 μm.FGFR-1 displays a spatially restricted pattern of expression in the
PE making it difﬁcult to determine whether each of the PE-derived
cells express FGFR-1 at some point. The retroviral injection technique
employed here does not allow us to speciﬁcally infect a sub-
population of PE cells, but rather infect a fraction of PE cells
indiscriminately. Nevertheless, compared to controls, clear changes
were observed in the proportion of test virus-infected PE progeny
undergoing epicardial EMT, invading the myocardium, and adopting
coronary vascular lineages. This allowed us to analyse the cell-
autonomous role of FGFR-1 in PE-derived cells in mosaic embryos,
thus avoiding potentially confounding problems associated with
whole-tissue gene deletion and embryonic lethality.
Previous studies using quail-chick chimerae have indicated that
epicardium-derived cells contribute to atrio-ventricular cushions and
valves (Gittenberger-de Groot et al., 1998;Männer,1999). Althoughwe
focused our attention on the coronary vascular lineages in this study,
we did not encounter X-Gal+ cells in the AV or OFT cushions. This
apparent discrepancy could be due to the differences between the viral
targeting of PE cells used in this study and the chimeric transplantation
used in the previous studies. The chimeric techniquewere typiﬁed by i)
the inclusion of part of the donor liver primordium, ii) on occasions, the
analysis of later-stage embryos, or iii) in some instances, transplanting
donor tissue to the inner curvature of recipient hearts rather than
adjacent to the sinus venosis. In addition, the viral targeting used in
this study will label a portion of PE cells and it is possible that a minor
population of PE-derived cells (eg. AV or OFT cushion cells) could go
undetected. It is also worth noting that FGFR signaling affects
differentiation of other mesoderm-derived lineages, although this
was not speciﬁcally tested in this study. As we focused on the coronary
vascular lineages, the antibodies used will only identify vascular
smooth muscle and endothelial cells (and their precursors). It remains
unknownwhether FGFR signaling occurs in other epicardium-derived
cell types and, therefore, we cannot rule out that differentiation of
other mesoderm-derived lineages is affected. Another unanswered
question is whether PE progeny with altered FGFR-1 expression are
able to co-express endothelial and smooth muscle markers. Due to
technical limitations associated with the antibodies used being mouse
IgG molecules, co-staining was not performed. We were, therefore,
unable to determine if any X-Gal+ cells co-expressed both markers.
Amongst PE progeny that had been infected with antisense FGFR-1
virus, we did not observe a reduction in the proportion that could
undergo epicardial EMT. By contrast, PE explants cultured with
SU5402, an inhibitor of all FGFRs, showed a marked inhibition of
EMT. This difference may reﬂect the varied experimental systems or,
alternatively, be suggestive of functional redundancy amongst FGFRs
in epicardial EMT. As mentioned above, FGFR-1 and FGFR-2 have been
shown to act redundantly in the myocardium (Lavine et al., 2006,
2005). It remains to be determined whether other FGFRs play a
redundant role with FGFR-1 in the epicardium and epicardium-
derived cells. Retroviral over-expression of FGFR-1 in the embryonic
PE and constitutive activation of the FGFR signaling pathway in
established epicardial cells of explanted hearts both led to an increase
in the number of epicardial cells invading themyocardium. These data
are consistent with the idea that FGFR-mediated signaling promotes
active EMT and invasion in epicardium-derived cells.their invasiveness. (A) The proviral constructs pCXIZ (β-galactosidase) and pCAFR-1
after transient transfectionwith pCXIZ or pCAFR-1, as indicated. (B) Immunoblotting of
to endogenous FGFR-1, note the truncated, mutant form of FGFR-1 (arrow; Hart et al.,
T1 and phospho-STAT3 in pCAFR-1-transfected cells. (C–F) Transfected heart explants
D) Examples of pCXIZ-transfected explants. (E, F) Examples of pCAFR-1-transfected
reactive nuclei (open arrowheads) than pCXIZ-transfected cells (arrows). (G–J) Explants
J) Examples of pCAFR-1-transfected explants. Note the epicardial (arrows, G and H) and
lants. Note the epicardial (arrows, I and J), intra-myocardial (arrowhead, I), and sub-
. (K) Quantiﬁcation of the localization of X-Gal+ cells. Solid bars, values for epicardial
l localization. Error bars, standard deviation of the mean. ⁎P valueb0.005 for pCAFR-1-
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smooth muscle recruitment in the developing heart, X-Gal+/SMαA+
cells were not detected in control (and FGFR-1) virus-infected hearts at
E7 (Hood and Rosenquist, 1992; Vrancken Peeters et al., 1997).
Moreover, SMαA+ cells were never detected amongst the myocardium
(the location of myocardial ﬁbroblasts) at stages before overt
recruitment of vascular smooth muscle cells to the coronary
vasculature, indicating changes in X-Gal+/SMαA+ cells relate to the
coronary vascular smoothmuscle lineage.Wedid, however, observe an
increase in the proportion of SMαA+ cells in antisense FGFR-1 virus-
infected hearts at E7, although, ultimately, the proportion of SMαA+
cells was reduced after knock-down of FGFR-1 by E12. It is not clear
why there was a temporary, and seemingly premature, increase in
these populations in antisense FGFR-1 virus-infected hearts. One
possibility is that proper FGFR-1 expression maintains a progenitor
population in an undifferentiated state during coronary development
at earlier embryonic stages and that the experimental down-regula-
tion of FGFR-1 led to premature differentiation and exhaustion of the
progenitor pool. Indeed, FGFR expression levels (and FGFR-mediated
signaling) have been implicated in maintaining the undifferentiated
state of cells of contractile lineages until appropriate differentiation.
These include FGFR-1 in skeletal muscle (Itoh et al., 1996) and FGFR-2
in lung smooth muscle (De Langhe et al., 2006).
By contrast, we observed a marked increase in the proportion of
QH1+ cells in FGFR-1 virus-infected PE progeny, indicating FGFR-1
expression ultimately favours the endothelial lineage over the smooth
muscle lineage in PE cells. This notion is consistent with recent studies
showing high FGF activity promotes endothelial cell fate (Nakazawa
et al., 2006) and FGF2 favours the endothelial lineage over smooth
muscle lineage in ES-derived cells (Ishisaki et al., 2003). Lineage
tracing studies indicate that the coronary vascular lineages have
segregated at the PE stage (Mikawa and Fischman, 1992; Mikawa and
Gourdie, 1996). Here we show that altering FGFR-1 signaling affects
the differentiation of coronary endothelial and smooth muscle
lineages. There are a number of possible mechanisms by which
altering FGFR-1 levels in precursors led to a change in the proportion
of endothelial and smooth muscle cells: i) by altering the lineage of
already segregated coronary vascular precursors or ii) by positive or
negative selection for a particular lineage, thus altering their ﬁnal
number. Possible mechanisms by which FGFR signaling may affect the
relative numbers of cells of coronary vascular lineages are by
differential effects on cell survival and/or proliferation, depending
upon which cell type is acted on. Indeed, FGFs and FGFRs have been
shown to promote proliferation and survival in numerous cell types
(Powers et al., 2000; Slavin, 1995). Yet another possibility is that
changing the ultimate destination of PE-derived cells (due to altered
FGFR-1 levels) affected coronary lineage differentiation due to a
different extracellular environment. It remains a possibility that
altering FGFR-1 levels at the stages performed here was too late to
alter determination of particular coronary progenitors although
differentiation may have been altered. Currently it is not feasible to
target the coronary progenitors at stages earlier than the PE stage.
Recently, thymosin β4 signaling in the myocardium has been
shown to be necessary for coronary vessel formation in the embryo,
which may be related to altered levels of myocardial VEGF (Smart
et al., 2007). Adult epicardial cells in culture treated to undergo EMT
with thymosin β4, TGFβ1, BMP-2 or myocardin can adapt smooth
muscle, endothelial and ﬁbroblastic phenotypes, highlighting the
therapeutic potential of mobilised epicardial cells (Smart et al., 2007).
The data presented here further our understanding of the molecular
mechanisms that govern epicardial EMT, myocardial invasion, and
coronary lineage differentiation. They show that FGFR-1 plays a
redundant role in epicardial EMT and a non-redundant role in
myocardial invasion. Furthermore, precise regulation of FGFR-1 levels
in PE-derived cells is required for proper coronary vascular lineage
differentiation. Moreover, they reveal an uncoupling of the molecularprocesses that govern epicardial EMT and myocardial invasion. This
may open avenues for development of cellular therapies for coronary
artery diseases based on the ability to mobilise epicardial cells and,
potentially, control coronary lineage differentiation in vivo.
In summary, the key ﬁndings of this study are:
1. FGFR-1-mediated signaling is sufﬁcient but not necessary for
epicardial EMT.
2. FGFR-1-mediated signaling is necessary for epicardium-derived
cells to invade the myocardium.
3. FGFR-mediated signaling can modulate coronary vascular cell fate/
differentiation in the developing heart.
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